Compare LIC MF Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹200 | ₹500 |
Expense Ratio | 2.45 | 1.93 |
NAV | ₹28.87 | ₹422.25 |
Fund Started | 08 Feb 2019 | 04 Jun 1999 |
Fund Size | ₹86.00 Cr | ₹4130.76 Cr |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹200
₹500
Expense Ratio
2.45
1.93
NAV
₹28.87
₹422.25
Fund Started
08 Feb 2019
04 Jun 1999
Fund Size
₹86.00 Cr
₹4130.76 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | -3.33% | -1.09% |
3 Year | 19.75% | 23.81% |
5 Year | 11.89% | 16.93% |
1 Year
-3.33%
-1.09%
3 Year
19.75%
23.81%
5 Year
11.89%
16.93%
Equity | 98.46% | 95.82% |
Cash | 1.54% | 4.11% |
Equity
98.46%
95.82%
Cash
1.54%
4.11%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.47% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Torrent Pharmaceuticals Ltd. | 5.68% |
Cipla Ltd. | 5.56% |
Neuland Laboratories Ltd. | 4.85% |
Divi's Laboratories Ltd. | 4.64% |
Fortis Healthcare Ltd. | 4.50% |
Aurobindo Pharma Ltd. | 4.46% |
Piramal Pharma Ltd. | 4.32% |
Alkem Laboratories Ltd. | 3.41% |
Sun Pharmaceutical Industries Ltd. | 11.97% |
Divi's Laboratories Ltd. | 6.90% |
Max Healthcare Institute Ltd. | 5.63% |
Cipla Ltd. | 4.45% |
Lupin Ltd. | 4.23% |
Lonza Group Ag | 4.01% |
Acutaas Chemicals Ltd. | 4.00% |
Torrent Pharmaceuticals Ltd. | 3.60% |
Laurus Labs Ltd. | 3.50% |
Fortis Healthcare Ltd. | 3.34% |
Name | Karan Doshi | Tanmaya Desai |
Start Date | 31 Oct 2025 | 17 May 2024 |
Name
Karan Doshi
Tanmaya Desai
Start Date
31 Oct 2025
17 May 2024
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 08 Feb 2019 | 04 Jun 1999 |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
08 Feb 2019
04 Jun 1999